1. EXPRESSION OF PIM KINASES IN REED‐STERNBERG CELLS FOSTERS IMMUNE PRIVILEGE AND TUMOR CELL SURVIVAL IN HODGKIN LYMPHOMA. (June 2017) Authors: Szydlowski, M.; Prochorec‐Sobieszek, M.; Szumera‐Ciećkiewicz, A.; Derezińska, E.; Hoser, G.; Wasilewska, D.; Szymańska‐Giemza, O.; Jabłońska, E.; Białopiotrowicz, E.; Sewastianik, T.; Polak, A.; Czardybon, W.; Gałęzowski, M.; Windak, R.; Zaucha, J.; Warzocha, K.; Brzózka, K.; Juszczyński, P. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 398 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SEL120–34A, a specific, potent and orally bioavailable inhibitor of CDK8, targets STAT-dependent gene transcription in leukemia and lymphoma models. (December 2016) Authors: Zylkiewicz, E.; Rzymski, T.; Mikula, M.; Dreas, A.; Wiklik, K.; Wrobel, A.; Golas, A.; Dolata, I.; Wojcik, K.; Masiejczyk, M.; Statkiewicz, M.; Kuklinska, U.; Goryca, K.; Grochowsk, A.; Cabaj, A.; Bialas, A.; Mikulski, M.; Windak, R.; Ostrowski, J.; Brzozka, K. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗